Your browser doesn't support javascript.
loading
Durable Clinical Response to Pyrotinib After Resistance to Prior Anti-HER2 Therapy for HER2-Positive Advanced Gastric Cancer: A Case Report.
Huang, Le-Tian; Ma, Jie-Tao; Zhang, Shu-Ling; Li, Xiao-Han; Sun, Li; Jing, Wei; Zhao, Jian-Zhu; Wang, Yan-Ru; Han, Cheng-Bo.
Afiliación
  • Huang LT; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Ma JT; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Zhang SL; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Li XH; Department of Pathology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Sun L; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Jing W; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Zhao JZ; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Wang YR; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Han CB; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Front Oncol ; 9: 1453, 2019.
Article en En | MEDLINE | ID: mdl-31956604
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2019 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2019 Tipo del documento: Article País de afiliación: China